Key Projects and Impacts
Demonstrating impact, scale, and African-led innovation.
Bloom Public Health Group has implemented transformative public health, pharmaceutical, and diagnostic projects across multiple African countries. Our work spans regulatory strengthening, industrial development, policy reform, supply chain optimization, and laboratory accreditation — anchored in evidence, global best practices, and African expertise.
Lassa Fever Vaccine Development – Technical Support
Bloom Public Health provided strategic scientific input to support ongoing efforts toward the development of a Lassa fever vaccine.
Anambra State Laboratory Optimization Project (ASLOP)
Anambra State engaged Bloom Public Health to conduct a coordinated laboratory optimization intervention.
Delta Plus Diagnostics Laboratory (Niger Delta)
Bloom Public Health supported the establishment and scale-up of Delta Plus Diagnostics, a critical diagnostics hub in the Niger Delta region.
Laboratory Strengthening & Accreditation Projects – Nigeria, Rwanda, Cameroon, Botswana
Bloom Public Health supported the establishment and scale-up of Delta Plus Diagnostics, a critical diagnostics hub in the Niger Delta region.
Nigeria’s First National Vaccine Policy
Bloom Public Health provided high-level technical leadership to support the Federal Ministry of Health in developing Nigeria’s first-ever National Vaccine Policy.
Africa-Wide PIC/S Initiative (AwPI) – Regulatory Capacity Strengthening Across 22 Countries
Bloom Public Health served as a leading technical partner in the Africa-wide PIC/S Initiative (AwPI), supporting African National Medicines Regulatory Authorities (NMRAs) to strengthen their governance, regulatory systems, GMP inspection capacity, and overall compliance processes.
We would love to connect with you
Together, these subsidiaries form a unified engine driving Africa’s health security, manufacturing resilience, regulatory excellence, and evidence-based policymaking.
